AARP Georgia State Director, Debra Tyler-Horton, released the following statement today, applauding Reps. Sanford Bishop, Hank Johnson, John Lewis, Lucy McBath, and David Scott, of the U.S. House of Representatives for voting to pass H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.
WASHINGTON—Retail prices for 267 brand-name drugs commonly used by older adults surged by an average of 5.8% in 2018, more than twice the general inflation rate of 2.4%, according to new AARP Public Policy Institute (PPI) data released today. The annual average cost of therapy for one brand-name drug ballooned to more than $7,200 in 2018, up from nearly $1,900 in 2006.
Before we know it, winter will be right around the corner. The declining temperatures will have us wanting to stay in our houses, but what does this mean for our bodies? Here are three ways you can continue to keep your body active during the winter.
Your eyes aren’t tricking you: AARP’s drug-price-fighting Tyrannosaurus Rexes—known as the “Rx T. Rex”—are back and roaring about their mission to make high drug prices extinct. This time the mighty dinos are stomping around Capitol Hill and all across the nation, urging Congress to take a bite out of high drug prices.